CECI, LUDOVICA
 Distribuzione geografica
Continente #
NA - Nord America 244
EU - Europa 130
AS - Asia 67
SA - Sud America 2
AF - Africa 1
Totale 444
Nazione #
US - Stati Uniti d'America 241
IT - Italia 98
SG - Singapore 38
CN - Cina 16
PT - Portogallo 6
SE - Svezia 6
IN - India 5
ID - Indonesia 4
IE - Irlanda 4
CH - Svizzera 3
CA - Canada 2
DE - Germania 2
GB - Regno Unito 2
RO - Romania 2
TH - Thailandia 2
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
FR - Francia 1
JP - Giappone 1
LV - Lettonia 1
MX - Messico 1
NL - Olanda 1
TR - Turchia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 444
Città #
Rome 44
Fairfield 28
New York 26
Ashburn 21
Singapore 20
Houston 13
Cambridge 11
Woodbridge 10
Seattle 9
Wilmington 9
San Paolo di Civitate 6
Amalfi 5
Milan 5
Turin 5
Boston 4
Dublin 4
Indianapolis 4
Lawrence 4
Lisbon 4
Mercato San Severino 4
Millbury 4
Princeton 4
Yogyakarta 4
Ann Arbor 3
Stockholm 3
Adelfia 2
Atlanta 2
Austin 2
Bangkok 2
Bühl 2
Chandler 2
Council Bluffs 2
Ermesinde 2
Paderno Dugnano 2
Revere 2
Rochester 2
Rockville 2
Saint-Sulpice 2
San Diego 2
Shanghai 2
Toronto 2
Amsterdam 1
Andover 1
Bari 1
Bologna 1
Buenos Aires 1
Cingoli 1
Dearborn 1
Edinburgh 1
Georgetown 1
Istanbul 1
Lappeenranta 1
Mianyang 1
Montesilvano Marina 1
North Bergen 1
Padova 1
Plano 1
Pomezia 1
Prague 1
Redwood City 1
Salerno 1
Sassari 1
Silverton 1
Sofia 1
São Paulo 1
Trumbull 1
Wandsworth 1
Yancheng 1
Zurich 1
Totale 314
Nome #
Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis 60
Cholangiocarcinoma: bridging the translational gap from preclinical to clinical development and implications for future therapy 50
Knockout of the tachykinin receptor 1 in the Mdr2−/− (Abcb4−/−) mouse model of primary sclerosing cholangitis reduces biliary damage and liver fibrosis 48
Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis 36
Functional role of the secretin/secretin receptor signaling during cholestatic liver injury 35
Endoplasmic reticulum stress: a possible connection between intestinal inflammation and neurodegenerative disorders 31
The emerging role of ferroptosis in liver cancers 30
p16 INK4A drives non-alcoholic fatty liver disease phenotypes in high fat diet fed mice via biliary e2f1/foxo1/igf-1 signaling 29
Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury 17
Knockout of secretin ameliorates biliary and liver phenotypes during alcohol-induced hepatotoxicity 16
Molecular mechanisms linking risk factors to cholangiocarcinoma development 14
FGF1 signaling modulates biliary injury and liver fibrosis in the Mdr2-/- mouse model of primary sclerosing cholangitis 13
Mast cells in liver disease progression: an update on current studies and implications 12
Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes 12
Kupffer cells: inflammation pathways and cell-cell interactions in alcohol-associated liver disease 11
Prolonged administration of melatonin ameliorates liver phenotypes in cholestatic murine model 10
The effects of taurocholic acid on biliary damage and liver fibrosis are mediated by calcitonin-gene-related peptide signaling 10
Downregulation of p16 decreases biliary damage and liver fibrosis in the Mdr2/ mouse model of primary sclerosing cholangitis 9
Mast cells selectively target large cholangiocytes during biliary injury via H2HR-mediated cAMP/pERK1/2 signaling 9
The functional roles of immune cells in primary liver cancer 8
Th e emerging role of ferroptosis in course of liver fibrosis 8
Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2-/- mouse model of primary sclerosing cholangitis (PSC) 8
Cyclic AMP signaling in biliary proliferation: a possible target for cholangiocarcinoma treatment? 8
Modulation of the tryptophan hydroxylase 1/monoamine oxidase-A/5-hydroxytryptamine/5-hydroxytryptamine receptor 2A/2B/2C axis regulates biliary proliferation and liver fibrosis during cholestasis 8
Circadian rhythm and melatonin in liver carcinogenesis: updates on current findings 8
Mast cells promote nonalcoholic fatty liver disease phenotypes and microvesicular steatosis in mice fed a western diet 8
Amelioration of Ductular reaction by stem cell derived extracellular vesicles in MDR2 knockout mice via Lethal-7 microRNA 7
null 7
Possible application of melatonin treatment in human diseases of the biliary tract 7
Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes 7
Inhibition of secretin/secretin receptor axis ameliorates NAFLD phenotypes 5
Gallstone and gallbladder disease: biliary tract and cholangiopathies 5
Prolonged administration of a secretin receptor antagonist inhibits biliary senescence and liver fibrosis in Mdr2-/- mice 3
Totale 549
Categoria #
all - tutte 3.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 1 0 0 1 2 3 2 2 4 1 2 0
2020/202172 1 1 2 0 0 29 4 2 2 18 6 7
2021/202243 0 2 1 5 6 7 0 2 3 1 8 8
2022/2023142 7 10 0 0 0 0 8 2 2 46 26 41
2023/2024252 24 31 20 21 26 37 5 18 6 22 15 27
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 549